Health technology assessment (HTA) programmes—as exemplified by the National Institute for Health and Care Excellence (NICE) HTA programme in the United Kingdom1—evaluate health technologies for their clinical effectiveness and cost-effectiveness after regulatory approval. The purpose of this evaluation system is to provide robust, evidence-based guidance through which key decision makers, principally at a health-system level, can understand the clinical and economic consequences of adopting a given technology.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: